| LLY | Eli Lilly and Co | 11.87% |
| UNH | UnitedHealth Group Inc | 5.54% |
| NOVO-B.CO | Novo Nordisk AS Class B | 5.23% |
| MRK | Merck & Co Inc | 4.12% |
| TMO | Thermo Fisher Scientific Inc | 3.98% |
| RHHBY | Roche Holding AG ADR | 3.94% |
| JNJ | Johnson & Johnson | 3.84% |
| AZN.L | AstraZeneca PLC | 3.82% |
| CYTK | Cytokinetics Inc | 3.54% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 3.45% |
No recent news for HRTS. The ingest cron pulls every 15 minutes during market hours.
The Tema Heart & Health ETF (HRTS) seeks to invest in companies that potentially stand to benefit from further advances in biotechnology and healthcare, specifically companies involved in cardiology, metabolic diseases and weight loss therapies.
Tema Cardiovascular and Metabolic ETF · Issued by Tema